Skip to main content
Services
Technology
Technology
YoctoReactor
Binder Trap Enrichment ®(BTE)
Cellular Binder Trap Enrichment®(cBTE)
Company
Company
Partners
Career
Art
Partners
Partners
Aurigene Pharmaceutical Services
SARomics Biostructures
Boo Kyung S·M Co.
Articles
Resources
Resources
Publications
FAQ
Conferences
News
Posters
Contact
Inquiry
Services
Services
Small molecule drug discovery for even hard-to-drug targets - identify inhibitors, binders and modulators
In living cell
In vitro
Molecular Glue Direct
In living cell
In vitro
PPI Inhibitor Direct
In living cell
In vitro
Integral membrane proteins
In living cell
In vitro
Selectivity Direct – multiplexed screening of target and anti-targets
In living cell
In vitro
Express - optimized for fast turn-around-time
In living cell
In vitro
Snap - easy, fast, and affordable
In living cell
In vitro
Technology
Technology
YoctoReactor
Accelerate molecular discovery with YoctoReactor
®
YR Libraries – advanced automation for efficient screening and optimization.
Read more
Binder Trap Enrichment
Streamline drug discovery with Binder Trap Enrichment
®
– enabling precise and efficient identification of high-affinity binders.
Read more
Cellular Binder Trap Enrichment
Enhance drug discovery with Cellular Binder Trap Enrichment
®
– enabling efficient identification of cellular target binders.
Read more
Partnering with
Vipergen
From straightforward Fee-For-Service to comprehensive joint ventures, we provide flexible partnership structures to align with your project’s distinct needs.
Explore our services
Resources
Articles
DNA-Encoded Libraries
DNA-Encoded Libraries
Medicinal Chemistry Services for DNA-Encoded Library Screening
The Advantages of Using DNA-Encoded Libraries (DELs) in Hit Identification Compared to Traditional High-Throughput Screening (HTS)
DNA-Encoded Libraries vs. Fragment-Based Screening: Pros and Cons
DNA Encoded Libraries: Principle of DNA-Compatible Chemical Reactions for High-Throughput Small Molecule Discovery
Understanding DEL Screening: From Target Binding to Hit Validation
Synthesis of DNA Encoded Libraries for Drug Discovery
Hit Identification & Screening
Hit Identification & Screening
Molecular Display Systems in Drug Discovery: Principles, Platforms, and Applications
From Target to Therapy: A Comprehensive Overview of the Drug Discovery Workflow
High-Throughput Screening in Drug Discovery
Revolutionizing Research with Chemical Libraries
Hit Identification in Drug Discovery
Target Classes
Target Classes
Transporters as Drug Targets: Strategies for Modern Ligand Discovery
Intrinsically Disordered Proteins as Drug Targets
Protein-Protein Interactions as Drug Targets
Enzymes as Drug Targets: DEL Screening for Enzyme Inhibitor Discovery
Structural Proteins as Drug Targets
Ion Channels as Drug Targets
Receptors as Drug Targets
Unlocking the Secrets of Kinases in Cellular Regulation
Transcription Factor Inhibitors: From “Undruggable” to Drug Discovery Reality
Protein-Protein Interactions in Disease and Pharmacology: Unlocking New Frontiers in Drug Discovery
Therapeutic Strategies
Therapeutic Strategies
Spatial Pharmacology: Organelle Targeting and Condensate-Mediated Drug Discovery
Next-Generation Targeted Protein Degradation: Beyond Classical PROTACs
Synthetic Lethality and Context-Dependent Cancer Targeting
RNA-Targeted Small Molecules and Translation-Modulating Therapeutics
Autophagy and Lysosome-Based Targeted Degradation Technologies
Choosing the Right Inhibitor Strategy: Antagonists, Agonists, Allosteric & Covalent Inhibitors in Modern Drug Discovery
Xenopus Oocytes in Human Protein Research and Drug Discovery
Small Molecule Drugs: Principles of Drug-Likeness and Molecular Design for Optimal Therapeutic Efficacy
How Molecular Glue is Transforming Drug Discovery
Targeted Protein Degradation
Platforms & Assays
Platforms & Assays
Unlocking the Potential of Cell-Based Assays in Modern Scientific Research
Molecular Display Systems in Drug Discovery: Principles, Platforms, and Applications
Xenopus Oocytes in Human Protein Research and Drug Discovery
Therapeutic Areas
Therapeutic Areas
CNS Drug Discovery
Cancer Drug Discovery
Why us
Company
Cases
Drug discovery for Academic research
Drug discovery for Pharmaceutical companies
Drug discovery for Biotech
Get In Touch
Menu
Vipergen ApS
Gammel Kongevej 23A
1
st
floor
1610 Copenhagen
Denmark
VAT: DK28851758
[email protected]
Partnering with
Vipergen
From straightforward Fee-For-Service to comprehensive joint ventures, we provide flexible partnership structures to align with your project’s distinct needs.
Explore our services
Partners
Aurigene Pharmaceutical Services
SARomics Biostructures
Boo Kyung S.M Co.
Company
About us
Team
In brief
Career
Art
Cases
Resources
Publications
FAQ
Conferences
News
Articles
Posters
Latest news
Domainex and Vipergen Partner to Accelerate Hit and Lead Discovery
September 1, 2026
Vipergen Expands DEL Series with Two Updated Libraries
August 28, 2026
Vipergen EPO Patent Maintained Following Opposition
May 20, 2026
Conferences
Protein-Protein Interactions (PPI) 2026
Conferences
Protein-Protein Interactions (PPI) 2026
Title of talk: Discovery of Molecular Glues for Novel Therapeutic Modality
London, UK
Dec 2, 2026
https://www.soci.org/events/fine-chemicals-group/2026/proteinprotein-interactions-ppi-2026
